HOME >> MEDICINE >> NEWS
E-mail can be good for you

A steady diet of e-mails that promote healthy behavior can change a person's outlook and behavior regarding healthier eating and increased physical activity, says a new study from the University of Alberta.

The 12 week study of 2,598 Canadian workers will be published in the July/August 2005 edition of the American Journal of Health Promotion.

People receiving the e-mails showed an increase in physical activity levels and also had more confidence in being able to participate in physical activity at the study's end. They also recognized more pros and fewer cons to physical actiivty and were more open to making dietary changes.

Further, those receiving e-mails actually reduced their mean body mass index (BMI), a measure of body fat based on height and weight, over the course of the study. By contrast, the mean BMI of the control group (people who did not receive the e-mails) slightly increased during the study period.


'"/>

Contact: Ryan Smith
ryan.smith@ualberta.ca
780-492-0436
University of Alberta
30-Jun-2005


Page: 1

Related medicine news :

1. Takeda responds to the FDA advisory committee recommendation
2. Takeda submits new drug application for extended-release type 2 diabetes medication, ACTOplus met
3. Sucampo Pharmaceuticals submits supplemental new drug application for Lubiprostone to treat IBS-C
4. Sucampo submits new drug application for lubiprostone
5. Brightening prospects of using fluorescent nanotubes in medical applications
6. Panbio files first patent application for Homogenous Assay Technology
7. LOral accepting applications for 2007 USA fellowships for Women in Science
8. NIH wrongly blamed for reduced success rate of grant applications
9. Magnet lab researcher exploring science behind commercial applications of liquid helium
10. Dalai Lama, top scientists to discuss science & clinical applications of meditation
11. Mechanism controlling DNA damage response has potential novel medical applications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick Taché ... Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a ... & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology:
Cached News: